Steroid Cell Tumor, Malignant
1 clinical trials · Condition
◉ Watch Steroid Cell Tumor, Malignant
| Record | Firm | Date |
|---|---|---|
| Erdafitinib in Metastatic Steroid-cell Ovarian Cancer (NCT06328491) | University Health Network, Toronto | 2022-05-30 |
Track Steroid Cell Tumor, Malignant automatically
Every clearance here is in the API, with alerts when new ones post.